Capital Stock (Narrative) (Details) $ in Thousands		6 Months Ended
	May 14, 2021 USD ($) shares	Jun. 30, 2022 shares	Dec. 31, 2021 shares	Jun. 30, 2021 shares	May 14, 2021 $ / shares	May 11, 2021 shares	May 10, 2021 shares
Class of Stock [Line Items]
Common stock, shares authorized		450,000,000	450,000,000	450,000,000		450,000,000	200,000,000
Number of shares issued		19,381,223
Atai Life Sciences [Member]
Class of Stock [Line Items]
Ownership interest acquired by equity investment						25.00%
Amount of investment | $	$ 12,346,300
Percentage of issued and outstanding common stock	25.00%	21.00%
Number of shares issued	37,300,000
Number of warrants issued	22,380,000
Proceeds from issuance of common stock and warrants | $	$ 12,346,300
Exercise price of warrants | $ / shares					$ 0.35
Warrants term					3 years
Securities Purchase Agreement [Member] | Atai Life Sciences [Member]
Class of Stock [Line Items]
Maximum rights to subscribe additional units	130,000,000
Right to subscribe additional units, description	Each additional unit will be comprised of (i) one share of common stock and (ii) one half of one warrant. The price for the additional units will be (i) until the date which is 12 months following the closing, $0.331 (subject to certain exceptions), and (ii) following the date which is 12 months following the closing, the lower of (A) a 20% premium to the market price on the date of purchase, and (B) $0.50 if purchased in the second year following closing and $0.75 if purchased in third year following closing. Each additional warrant will entitle atai, for a period of three years from the date of issuance, to purchase one share at the lesser of either (i) a 20% premium to the price of the corresponding additional share, or (ii) the price per share under which shares of the Company are issued under convertible instruments that were outstanding on February 16, 2021
Maximum number of common shares called by warrants that may not be exercised	44,000,000